HomeCompareGGLT vs MRK

GGLT vs MRK: Dividend Comparison 2026

GGLT yields 1.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $35.7K in total portfolio value
10 years
GGLT
GGLT
● Live price
1.00%
Share price
$200.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.1K
Annual income
$106.71
Full GGLT calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GGLT vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGGLTMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GGLT + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GGLT pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GGLT
Annual income on $10K today (after 15% tax)
$85.00/yr
After 10yr DRIP, annual income (after tax)
$90.70/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,237.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GGLT + MRK for your $10,000?

GGLT: 50%MRK: 50%
100% MRK50/50100% GGLT
Portfolio after 10yr
$38.9K
Annual income
$4,952.42/yr
Blended yield
12.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GGLT
No analyst data
Altman Z
-0.3
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GGLT buys
0
MRK buys
0
No recent congressional trades found for GGLT or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGGLTMRK
Forward yield1.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$21.1K$56.8K
Annual income after 10y$106.71$9,798.13
Total dividends collected$1.0K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GGLT vs MRK ($10,000, DRIP)

YearGGLT PortfolioGGLT Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,800$100.00$11,206$366.19$406.00MRK
2$11,657$100.93$12,650$502.35$993.00MRK
3$12,575$101.82$14,407$694.19$1.8KMRK
4$13,558$102.65$16,585$967.82$3.0KMRK
5$14,610$103.43$19,342$1,363.89$4.7KMRK
6$15,737$104.17$22,913$1,947.19$7.2KMRK
7$16,943$104.86$27,662$2,823.89$10.7KMRK
8$18,235$105.51$34,159$4,173.35$15.9KMRK
9$19,618$106.13$43,337$6,308.80$23.7KMRK
10$21,097$106.71$56,776$9,798.13$35.7KMRK

GGLT vs MRK: Complete Analysis 2026

GGLTStock

Giant Group, Ltd., through its equity investment in Checkers Drive-In Restaurants, Inc., engages in the double drive-thru hamburger restaurant business in the United States. The company develops, produces, owns, operates, and franchises quick service double drive-thru restaurants under two brand names, Checkers and Rally's Hamburgers. The restaurants provide automobile-oriented service. As of December 29, 2003, Checkers and its franchisees owned 405 Checkers restaurants and 379 Rally's restaurants operating primarily in the United States. Giant Group was founded in 1899 and is based in Beverly Hills, California.

Full GGLT Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GGLT vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GGLT vs SCHDGGLT vs JEPIGGLT vs OGGLT vs KOGGLT vs MAINGGLT vs JNJGGLT vs ABBVGGLT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.